In this single-center study of patients with relapsing-remitting multiple sclerosis, nonmyeloablative hematopoietic stem cell transplantation was associated with improvement in neurological disability and other clinical outcomes.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados